These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11826612)

  • 1. Elevated basal ganglia glucose metabolism in cyclosporine neurotoxicity: a positron emission tomography imaging study.
    Meyer MA
    J Neuroimaging; 2002 Jan; 12(1):92-3. PubMed ID: 11826612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interregional correlations of glucose metabolism between the basal ganglia and different cortical areas: an ultra-high resolution PET/MRI fusion study using 18F-FDG.
    Kim JH; Son YD; Kim JM; Kim HK; Kim YB; Lee C; Oh CH
    Braz J Med Biol Res; 2017 Nov; 51(1):e6724. PubMed ID: 29160415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose Hypermetabolism in Contralateral Basal Ganglia Demonstrated by Serial FDG PET/CT Scans in a Patient With SLE Chorea.
    Niu N; Cui R
    Clin Nucl Med; 2017 Jan; 42(1):64-65. PubMed ID: 27819860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal ganglia and frontal lobe glucose metabolism. A reproducibility positron emission tomography study.
    Goldman S; Dethy S; Lotstra F; Biver F; Stanus E; Wikler D; Hildebrand J; Mendlewicz J; Luxen A
    J Neuroimaging; 1995 Oct; 5(4):219-26. PubMed ID: 7579750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional imaging for disorders of basal ganglia].
    Otsuka M; Taniwaki T
    Rinsho Shinkeigaku; 1999 Jan; 39(1):30-2. PubMed ID: 10377793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain metabolism changes with 18F-fluorodeoxy- glucose-positron emission tomography in a patient with Cotard's syndrome.
    Ozkan N; Caliyurt O
    Aust N Z J Psychiatry; 2016 Jun; 50(6):600-1. PubMed ID: 26681266
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute bilateral basal ganglia lesions in patients with diabetic uremia: an FDG-PET study.
    Wang HC; Hsu JL; Shen YY
    Clin Nucl Med; 2004 Aug; 29(8):475-8. PubMed ID: 15249822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography in myotonic dystrophy.
    Mielke R; Herholz K; Fink G; Ritter D; Heiss WD
    Psychiatry Res; 1993 Jun; 50(2):93-9. PubMed ID: 8378492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Positron emission tomography and basal ganglia functions].
    Kato M
    No To Shinkei; 1990 May; 42(5):450-60. PubMed ID: 2206633
    [No Abstract]   [Full Text] [Related]  

  • 10. Changing patterns of glucose metabolism during the course of subacute sclerosing panencephalitis as measured with 18FDG-positron-emission tomography.
    Huber M; Pawlik G; Bamborschke S; Fink GR; Karbe H; Schlenker M; Bewermeyer H; Heiss WD
    J Neurol; 1992 Mar; 239(3):157-61. PubMed ID: 1573420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of glucose metabolism in basal ganglia diagnosed with FDG-PET scan: a neuroacanthocytosis case.
    Selcuk NA; Fenercioglu A
    Clin Nucl Med; 2010 Jul; 35(7):557-8. PubMed ID: 20548161
    [No Abstract]   [Full Text] [Related]  

  • 12. Positron emission tomography in degenerative disorders of the dopaminergic system.
    Karbe H; Holthoff V; Huber M; Herholz K; Wienhard K; Wagner R; Heiss WD
    J Neural Transm Park Dis Dement Sect; 1992; 4(2):121-30. PubMed ID: 1571076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT.
    Zhang Q; Tian T; Wang L; Qiu H; Li D
    Biomed Pharmacother; 2016 Dec; 84():1331-1336. PubMed ID: 27810790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke.
    Meltzer CC; Kondziolka D; Villemagne VL; Wechsler L; Goldstein S; Thulborn KR; Gebel J; Elder EM; DeCesare S; Jacobs A
    Neurosurgery; 2001 Sep; 49(3):586-91; discussion 591-2. PubMed ID: 11523668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional significance of calcinosis of the basal ganglia via positron emission tomography].
    Staffen W; Karbe H; Rudolf J; Herholz K; Diederich N; Heiss WD
    Fortschr Neurol Psychiatr; 1994 Apr; 62(4):119-24. PubMed ID: 8206464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography.
    Wu JC; Gillin JC; Buchsbaum MS; Hershey T; Hazlett E; Sicotte N; Bunney WE
    Sleep; 1991 Apr; 14(2):155-62. PubMed ID: 1866529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tomographic mapping of human cerebral metabolism: normal unstimulated state.
    Mazzilotta JC; Phelps ME; Miller J; Kuhl DE
    Neurology; 1981 May; 31(5):503-16. PubMed ID: 6972012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
    Nagasawa H; Tanji H; Nomura H; Saito H; Itoyama Y; Kimura I; Tuji S; Fujiwara T; Iwata R; Itoh M; Ido T
    J Neurol Sci; 1996 Aug; 139(2):210-7. PubMed ID: 8856655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
    Thobois S; Guillouet S; Broussolle E
    Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes.
    Ivançević V; Alavi A; Souder E; Mozley PD; Gur RE; Bénard F; Munz DL
    Clin Nucl Med; 2000 Aug; 25(8):596-602. PubMed ID: 10944013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.